?

Lankler Douglas M

Executive Vice President
Pfizer Inc.
US, New York [HQ]
CIK 1488270

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
2,309,200,000
Price per Share :
$26.49
Equivalence :
$61,170,708,000.00

Transaction History

  • M
    Form 4
    2,309,200,000 Shares After Transaction
    Value : $63,133,528,000.00
    $26,179,417,000.00
    02/23/24
  • Footnotes:
    #1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
    #2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
    #3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
    #4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
  • F
    Form 4
    2,243,020,000 Shares After Transaction
    Value : $62,266,235,200.00
    $1,837,156,800.00
    02/23/24
  • F
    Form 4
    1,469,180,000 Shares After Transaction
    Value : $40,211,456,600.00
    $21,180,000,800.00
    02/23/24